Description
Boldenone undecylenate (Equipoise) is a veterinary anabolic steroid. Despite the molecules’ resemblance, the drug’s characteristics are totally different from Methandrostenolone. Without the 17-alpha-methyl group, Boldenone is Dianabol (this part of the molecule allows Dianabol to pass through the liver without breaking down). When comparing the effects of Boldenone undecylenate with Dianabol, the gains in bulk and strength are almost identical.
Boldenone Undecylenate 250mg is a testosterone molecule with a double carbon link between 1 and 2. Spectrum Boldenone Undecylenate 250mg now has anabolic effects comparable to testosterone, but its androgenic qualities are reduced by half. However, Spectrum Boldenone Undecylenate 250mg provides less effect than testosterone.
Spectrum Boldenone Undecylenate 250 mg effects:
- Boosts appetite, which is good for mass-gathering courses.
- Accelerates synthetic processes.
- It ensures a gradual but steady development of muscular mass.
- The delivery of oxygen to muscle cells improved, as did the blood’s red blood cell concentration.
- The number of capillaries in the muscle rises, increasing venousity.
- It is poor in aromatization (below methane).
- Unlike methandrostenolone, Boldenone may stabilize (activate) androgen receptors.
- Unlike other anabolic steroids, it does not inhibit testosterone production as significantly.
- The medication does not include antiestrogens.
- No libido inhibition.
Where to purchase Boldenone Undecylenate? – Boldenone Undecylenate for sale is suitable for beginners. Our service allows you to purchase Spectrum Pharma BOLD in USA.
Boldenone is an oil-based injectable anabolic steroid with the Undecylenate ester linked for a longer release rate and half-life. It is an anabolic derivative of Testosterone with a decreased androgenic impact. Equipoise is a veterinary product designed for use on animals. Equipoise is a less androgenic version of Testosterone with less Estrogenic action than Testosterone. Many users like to compare it to Nandrolone (Deca Durabolin), however this is a bad comparison since Nandrolone has different characteristics than Equipoise and comes from a different family of chemicals (a 19-nor, also known as a progestin). Many believe Nandrolone and Equipoise to be interchangeable in a cycle.
An interesting tidbit about this compound: Equipoise was created in 1949, long before Dianabol (Methandrostenolone), making it the first synthetic derivative of Testosterone. Furthermore, Dianabol is Equipoise (Boldenone) with a methyl group added to its 17-beta hydroxyl group (also known as C17-alkylation) to make it orally accessible in the body. Dianabol (Methandrostenolone) is really Equipoise C17-alkylated. The methylation at the 17th carbon atom altered enough characteristics of the molecule that it was deemed a distinct anabolic steroid analogue, and called Methandrostenolone (Dianabol). The methyl group attached to the 17th carbon on the Dianabol chemical structure is the only difference between the two. It is clear that these two anabolic steroids are almost identical.
Although Equipoise was created in 1949, it wasn’t commercialized until the 1960s as Parenabol. Between 1949 until its introduction in the 1960s, Ciba experimented with Equipoise, trying to improve its half-life and release rates. The Undecylenate ester was added and the final preparation was Boldenone Undecylenate. This chemical was tested clinically in the late 1960s and early 1970s as an anabolic steroid that would promote lean mass and prevent weight loss in patients with wasting and osteoporosis. Parenabol was removed off the market in the late 1970s due to lack of applicability and usage.
Squibb would subsequently acquire the patents for Boldenone and re-release it as Equipoise, a veterinary anabolic steroid designed for use in horses but also in other animals. Equipoise is renowned for its lean mass gains and appetite-stimulating effects, which are seen in virtually all anabolic steroids. However, Equipoise tends to increase hunger more than other anabolic steroids. Although the manufacturing and marketing of Equipoise has changed several times over the years, it is still accessible on the American and worldwide markets under various generic and brand names.
As previously stated, Equipoise is a synthetic derivative of Testosterone that has double-bonds inserted between carbon 1 and carbon 2 on the steroid molecule. This is the alteration that reduces Equipoise’s propensity for interacting with the aromatase enzyme (the enzyme responsible for the conversion of androgens into Estrogen). As a consequence, it has less Estrogenic action than Testosterone. Boldenone with an Undecylenate ester added. Undecylenate is Undecylenoic acid, however when linked to Boldenone it is an ester bond (or ester linkage). Boldenone’s 17-beta hydroxyl group is linked to undecylenoic acid. A prolonged release window is achieved by increasing the hormone’s release rate and half-life. Enzymes work to dissolve the ester-hormone link after Boldenone Undecylenate reaches the circulation, which takes time. These enzymes remove the ester from the hormone, resulting in pure Boldenone that can function in the body. The enzymes removing the ester from the hormone is what causes the slower release rates. Boldenone Undecylenate is created by attaching the Undecylenate ester to Boldenone, extending its half-life to 14 days.
The only structural difference between Equipoise and Dianabol is that Equipoise has an Undecylenate ester connected to its 17-beta hydroxyl group whereas Dianabol has a methyl group attached to it. The methyl group (also known as C17-alkylation) prevents the liver from metabolizing and breaking down Dianabol when taken orally. Both hormones are identical except for these minor changes. However, both of these hormones function substantially differently in the body, indicating that adding a methyl group (C17-alkylation) to the 17th carbon affects more than simply the hormone’s resistance to breakdown in the liver.
Equipoise has several characteristics with Testosterone as a derivative. As an aromatizable anabolic steroid, Equipoise may and does transform into Estrogen in the body when it interacts with the aromatase enzyme. In the body, its double-bond alterations between carbons 1 and 2 decrease its affinity for the aromatase enzyme.
Equipoise will still convert to Estrogen, although in far less amounts than its parent hormone Testosterone. However, the problem of Estrogenic side effects remains and should not be disregarded by any consumers. Thus, Equipoise alone will not eliminate possible water retention, but will greatly reduce it. While Equipoise should not cause bloating or other estrogenic side effects at reasonable and moderate dosages (depending on user sensitivity), the risk of these side effects increases with increasing Equipoise doses. Increasing dosages will enhance the rate of aromatization into Estrogen.
For those who are sensitive to androgenic side effects, Equipoise has a lower androgenic strength rating than its progenitor hormone Testosterone. Overall, Equipoise provides the similar anabolic gains in size, strength, and muscle as Testosterone, but with less estrogenic and androgenic adverse effects. Equipoise should provide excellent lean mass gains with little water retention (depending on dosage) and be a great complement to any bulking or lean mass cycle. It may potentially replace Nandrolone in a stack.
